Qin Zhou

11PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursDiagnostic radiography
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 30, 2026
DLST Succinylation-Mediated Mitochondrial Metabolic Remodeling and Cuproptosis Resistance Promote Malignant Progression of Lung Adenocarcinoma.

|May 14, 2026
Cost-effectiveness of adjuvant therapy with camrelizumab in high-risk locoregionally advanced nasopharyngeal carcinoma: from the perspective of the Chinese healthcare system.

|Jul 04, 2025
HDAC1/2-mediated deacetylation of KLF9 promotes the malignant progression of nasopharyngeal carcinoma via CDH17.

Kun Zhang, Xingzhi Peng, Peijun Zhou

|Jun 19, 2025
Ivonescimab plus chemotherapy in advanced or metastatic non‑squamous non‑small cell lung cancer with EGFR variant in China: a cost-effectiveness analysis.

Rong Long, Weilu Kuang, Qin Zhou

|Feb 24, 2024
Prognostic factors in surgically treated tongue squamous cell carcinoma in stage T1-2N0-1M0: A retrospective analysis.

Wenxi Wang, Yuxiang Wang, Wenhui Zeng

|Feb 18, 2024
Optimal sequence of LT for symptomatic BM in EGFR-mutant NSCLC: a comparative study of first-line EGFR-TKIs with/without upfront LT.

Lishui Niu, Honghua Wu, Ruihuan Gao

Pageof 2

Frequent Collaborators

2 joint publications

Xingzhi Peng

2 joint publications

Lifang Yang

1 joint publications

Zhanzhan Li

1 joint publications

Zhuo-Miao Ye